Ryvu Therapeutics SA

NEW
WAR:RVU (Poland)  
zł 17.5 +0.060 (+0.34%) Aug 12
At Loss
P/B:
9.79
Market Cap:
zł 404.60M ($ 108.25M)
Enterprise V:
zł 399.20M ($ 106.80M)
Volume:
59.48K
Avg Vol (2M):
35.15K
Trade In:
Volume:
59.48K
At Loss
Avg Vol (2M):
35.15K

Ryvu Therapeutics SA (WAR:RVU) Dividend

Ryvu Therapeutics SA (WAR:RVU) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: WAR:RVU Dividend

Does Ryvu Therapeutics SA (WAR:RVU) pay a dividend?

Ryvu Therapeutics SA (WAR:RVU) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Ryvu Therapeutics SA pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Ryvu Therapeutics SA has returned capital to shareholders via buybacks at a rate of -8% over the past 3 years.

What are dividend-paying alternatives to Ryvu Therapeutics SA?

For dividend-paying alternatives in Ryvu Therapeutics SA's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.